(Q34746501)

4 August 2017

1 reference

title

Treatment of fatigue in fibromyalgia (English)

1 reference

4 August 2017

0 references

2

Daniel J Clauw

1 reference

4 August 2017

Emma K Guymer

1

0 references

publication date

1 May 2002

1 reference

Rheumatic Diseases Clinics of North America

4 August 2017

1 reference

4 August 2017

28

1 reference

4 August 2017

2

1 reference

4 August 2017

367-378

1 reference

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Deployment stressors and a chronic multisymptom illness among Gulf War veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Is there a Persian Gulf War syndrome? Evidence from a large population-based survey of veterans and nondeployed controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Chronic multisymptom illness affecting Air Force veterans of the Gulf War.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

The measurement of fatigue: A new instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Defining and measuring fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

A randomized, controlled trial of exercise and education for individuals with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Antidepressant treatment of fibromyalgia. A meta-analysis and review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

A double-blind placebo controlled trial of fluoxetine in fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

A randomized controlled trial of citalopram in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

An open clinical trial of venlafaxine treatment of fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900007-2

7 January 2021

10.1016/S0889-857X(01)00007-2

Identifiers

DOI

1 reference

release_xqsmxfalvjbgpgx4kzt2tvm3gq

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xqsmxfalvjbgpgx4kzt2tvm3gq

24 November 2022

mapped directly with Wikidata item

PubMed ID

12122924

1 reference

PubMed ID

12122924